Merriman Curhan Ford
View Older Stories View More Recent Stories
-
Notable Analyst Rating Changes 8/21: SPWRA, GPS, CRM, LTD, UDR, JBL Upgraded; STP, DKS, INTU, LZ Downgraded
-
Merriman Curhan Ford Rates First Solar (FSLR) a Buy In Transitioned Coverage
-
Merriman Curhan Upgrades SunPower (SPWRA) To Buy In Transitioned Coverage
-
Merriman Curhan Ford Upgrades Super Micro Computer (SMCI) to Buy; Post 4Q Checks Suggest Improving Outlook.
-
Merriman Curhan Trims Price Target on Geron (GERN) Following FDA Clinical Hold
-
Merriman Curhan Initiates Coverage on InterMune (ITMN) with a Buy
-
Merriman Curhan Initiates Coverage on Salix Pharmaceutical (SLXP) with a Buy
-
Merriman Curhan Reiterates Bullish Stance On Dendreon (DNDN) Following Q2 Results/Call
-
Merriman Curhan Calls ValueClick (VCLK) A Great Value, Upgrades to Buy
-
Merriman Curhan Ford Upgrades Cree, Inc. (CREE) to Buy, LED Outlook Brighter
-
Merriman Curhan Reiterates Bullish Stance on Regeneron (REGN) Following "Vanilla" Q2
-
Merriman Curhan Ford Downgrades Ligand Pharmaceuticals (LGND) to Neutral
-
Notable Analyst Rating Changes 8/3: MMM, WEN, GPS, BIDU, JCP, OWW, NDAQ Upgraded; HURN, ANN, E, ROST Downgraded
-
Merriman Curhan Ford Starts Helix Biopharma Cp (HXBPF) at Buy
-
Unusual 11 Mid-Day Movers 7/31: ANDS, IBNK, INO, DSCM Higher; SYNA, ARIA, SFI, PIR Lower
-
Merriman Curhan Downgrades ARIAD Pharma (ARIA) to Sell
-
FUQI International (FUQI) Prices 4.86M Share Offering at $21.50
-
Merriman Curhan Ford Downgrades Akamai Technologies (AKAM) to Neutral; Stepping to Sidelines
-
Micromet (MITI) Announces Pricing of 14M Shares AT $5.00 Per Share
-
Merriman Curhan Maintains Bullish Stance On FUQI Intl (FUQI) Ahead of Equity Pricing
-
Notable Analyst Rating Changes 7/28: X, AA, ENOC, IR, UFS Upgraded; DB, PM, WGOV, CRM Downgraded
-
Merriman Curhan Initiates Coverage on VIVUS (VVUS) with a Buy
-
Merriman Curhan Initiates Coverage on Celgene (CELG) with a Buy
-
Merriman Curhan Initiates Coverage on Cinemark Holdings (CNK) with a Buy
-
Merriman Curhan Upgrades optionsXpress Holdings (OXPS) to Neutral
-
EMC (EMC) volatility low at 39 into EPS and margin outlook
-
Merriman Curhan Initiates Coverage on EMC Corp (EMC) with a Buy
-
Notable Analyst Rating Changes 7/15: GS, ALU, ICE, MCO, ADBE, MI Upgraded; PTR, PAR, UFS, PCL Downgraded
-
Merriman Curhan Downgrades 3PAR (PAR) to Neutral
-
Notable Analyst Rating Changes 7/14: BK, UL, VMW, CNK, NILE Upgraded; MNKD, MAS, BKC, VOD Downgraded
-
Merriman Curhan Ford Starts Fairchild Semiconductor (FCS) at Buy
-
Merriman Curhan Initiates Coverage on Supertex (SUPX) with a Buy
-
Merriman Curhan Upgraded Rick's Cabaret (RICK) to Buy
-
Merriman Curhan Boosts Price Target Range on Dendreon (DNDN) to $49-$50
-
Merriman Curhan Ford Initiates Coverage on Repligen (RGEN)
-
Merriman Curhan Upgrades to Regal Entertainment Group (RGC) to Buy
-
Sangamo Biosciences (SGMO): Merriman believes SGMO shares should trade to a range of $10-11
-
Merriman Curhan Resumes Coverage on Itron (ITRI) with a Neutral
-
Merriman Curhan Initiates Coverage on AIXTRON AG (AIXG) with a Buy
-
Merriman Curhan Initiates Coverage on FEI Company (FEIC) with a Buy
-
Merriman Curhan Initiates Coverage on Veeco Instruments (VECO) with a Buy
-
Merriman Curhan Initiates Coverage on Several Industrial Metals & Minerals Stocks
-
Merriman Curhan Upgrades Blue Coat Systems (BCSI) to Buy
-
Merriman Curhan Downgrades Regal Entertainment Group (RGC) to Neutral
-
Merriman Curhan Downgrades Exide Technologies (XIDE) to Hold
-
Merriman Curhan Downgrades Exide Tech. (XIDE) to Neutral
-
Merriman Curhan Downgrades Ascent Solar Technologies (ASTI) to Neutral
-
Notable Analyst Rating Changes 5/22: AAUK, POT, MOS, AGU, ARUN, GPS Upgraded; MON, EGLE,
-
Merriman Curhan Initiates Coverage on Teradata (TDC) with a Neutral
-
Notable Analyst Rating Changes 4/24: RIMM, AMGN, INFA, CAKE Upgraded; MAR, SPWRA, TOL, PTR Downgraded

